BioCentury
ARTICLE | Company News

Amarin Technologies, Helm AG deal

December 20, 2010 8:00 AM UTC

Chemical company Helm purchased a 30% interest in Amarin Technologies. Amarin Technologies produces new formulations of established drugs using its transdermal drug delivery technology. Further terms ...